Amyloidosis Cardiac Clinical Trial
Official title:
Ultrasound Therapy In Cardiac Amyloidosis
This is a prospective pilot clinical study of subjects with cardiac amyloidosis and control subjects without amyloidosis where we plan to evaluate changes in myocardial blood flow, systolic and diastolic function before and after sonotherapy.
70 subjects will be enrolled in this study in 3 study groups: A) 30 subjects with light chain cardiac amyloidosis B) 30 subjects with transthyretin cardiac amyloidosis and C) 10 subjects without amyloidosis. All subjects will undergo rest 2D echocardiography, rest N-13 ammonia or rubidium-82 perfusion PET, Definity infusion with high mechanical index (MI) imaging defined as sonotherapy in this study protocol. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04985734 -
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Patients With Idiopathic Peripheral Neuropathy
|
N/A | |
Recruiting |
NCT05489549 -
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
|
||
Enrolling by invitation |
NCT05718401 -
The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics
|
||
Recruiting |
NCT05167799 -
Cardiac Contractility Modulation Therapy in Amyloid Cardiomyopathy Patients With Heart Failure
|
||
Completed |
NCT03996382 -
Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome
|
N/A | |
Recruiting |
NCT06066632 -
Analysis of Calcium Score of Severe Aortic Stenosis in Patients With and Without Cardiac Amyloidosis (CAUSATIVE Study)
|
||
Recruiting |
NCT05379101 -
Intracardiac Flow Assessment in Cardiac Amyloidosis
|
||
Recruiting |
NCT06186167 -
Amyloidosis Incidence in High-Risk Cardiac Device Patients
|
||
Recruiting |
NCT06251778 -
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
|
||
Recruiting |
NCT03984877 -
Impact of Amyloidosis on TAVI Patients
|
||
Completed |
NCT04298372 -
Frontline Lenalidomide for AL Amyloidosis Involving Myocardium
|
Phase 3 | |
Not yet recruiting |
NCT05938218 -
Virtual Reality Assisted Patient Empowerment: Diagnose ATTR-Amyloidosis And Start Treatment
|
N/A | |
Active, not recruiting |
NCT04061213 -
ATTR Amyloidosis in Elderly Patients With Aortic Stenosis
|
||
Recruiting |
NCT04587648 -
Cardiac Amyloidosis in HFpEF
|